Panacea Biotec Limited has informed the Exchange regarding Resignation of Mr. Devender Gupta as Chief Financial Officer of the company w.e.f. December 15, 2025.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec Limited has informed the stock exchange about the resignation of Mr. Devender Gupta from the position of Chief Financial Officer, effective December 15, 2025. The CFO is a key managerial personnel under the Companies Act, and his exit creates a vacancy in the company's top finance leadership. No reason for the resignation or details of a successor have been disclosed in this filing. Investors will likely watch for a subsequent announcement regarding the appointment of a new CFO.
CFO exits at mid-to-senior level can be viewed as a leadership gap that may temporarily affect financial reporting continuity, though the impact depends on the reason for departure and how quickly a replacement is appointed.